Patents Assigned to Mitomics Inc.
  • Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
    Patent number: 8715960
    Abstract: The present invention provides novel mitochondrial fusion transcripts, the parent mutated mtDNA molecules, and the resulting translation products (proteins) for predicting, diagnosing and/or monitoring cancer. Hybridization probes complementary thereto for use in the methods of the invention are also provided.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: May 6, 2014
    Assignee: Mitomics Inc.
    Inventors: Ryan Parr, Gabriel Dakubo, Andrew Harbottle, Brian Reguly, Jennifer Creed, Kerry Robinson, Daniel Klein
  • Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
    Patent number: 8008008
    Abstract: Mitochondrial DNA deletions useful for the detection of cancers and sun exposure are provided. In particular, methods and kits for detecting mitochondrial DNA deletions for the early detection, diagnosis and progression of prostate cancer, sun exposure and non-melanoma skin cancer are provided.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: August 30, 2011
    Assignee: Mitomics Inc.
    Inventors: Ryan Parr, Robert Thayer, Gabriel Dakubo, Jennifer Maki, Kerry Robinson, Andrea Maggrah, Brian Reguly, Andrew Harbottle, Mark Birch-Machin